The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
The ETS family of oncogenic transcription factors in solid tumours
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage
Lee, H., Yoon, C., Schmidt, B. H., Park, D. J., Zhang, A. Y., Erkizan, H. V., Toretsky, J. A., Kirsch, D. G., & Yoon, S. S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0338 · Cited by 85
RetractedRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Mateo, J., Carreira, S., Sandhu, S., Miranda, S., Mossop, H., Perez-Lopez, R., Nava Rodrigues, D., Robinson, D., Omlin, A., Tunariu, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506859 · Cited by 2,185
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
MITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Asangani, I. A., Dommeti, V. L., Wang, X., Malik, R., Cieslik, M., Yang, R., Escara-Wilke, J., Wilder-Romans, K., Dhanireddy, S., Engelke, C., et al. (2014) · Nature · doi:10.1038/nature13229 · Cited by 927
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
Tognon, C., Knezevich, S. R., Huntsman, D., Roskelley, C. D., Melnyk, N., Mathers, J. A., Becker, L., Carneiro, F., MacPherson, N., Horsman, D., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00180-0 · Cited by 911
Frequency of TERT promoter mutations in human cancers
Vinagre, J., Almeida, A., Pópulo, H., Batista, R., Lyra, J., Pinto, V., Coelho, R., Celestino, R., Prazeres, H., Lima, L., et al. (2013) · Nature Communications · doi:10.1038/ncomms3185 · Cited by 898
Yu, J., Yu, J., Mani, R.-S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.018 · Cited by 850
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., et al. (2007) · Nature · doi:10.1038/nature06024 · Cited by 844
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., et al. (2009) · Nature Genetics · doi:10.1038/ng.370 · Cited by 659
Ibrahim, Y. H., García-García, C., Serra, V., He, L., Torres-Lockhart, K., Prat, A., Anton, P., Cozar, P., Guzmán, M., Grueso, J., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0348 · Cited by 601
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566
Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., & Turc-Carel, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06137.x · Cited by 539
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H. M., Vickers, E., A'Hern, R., Levink, R., Coumans, F., Moreira, J., Riisnaes, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3667 · Cited by 533
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.
Lin, B., Ferguson, C., White, J. T., Wang, S., Vessella, R. L., True, L. D., Hood, L., & Nelson, P. S. (1999) · PubMed · Cited by 531
Bastian, B. C., LeBoit, P. E., Hamm, H., Bröcker, E.-B., & Pinkel, D. (1998) · PubMed · Cited by 513
Pten in stromal fibroblasts suppresses mammary epithelial tumours
Trimboli, A. J., Cantemir-Stone, C. Z., Li, F., Wallace, J. A., Merchant, A., Creasap, N., Thompson, J. C., Caserta, E., Wang, H., Chong, J.-L., et al. (2009) · Nature · doi:10.1038/nature08486 · Cited by 500
Self-citationThe ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499
Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D., & Stehelin, D. (1990) · Nature · doi:10.1038/346191a0 · Cited by 496
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Zhu, J., Sammons, M. A., Donahue, G., Dou, Z., Vedadi, M., Getlik, M., Barsyte-Lovejoy, D., Al-awar, R., Katona, B. W., Shilatifard, A., et al. (2015) · Nature · doi:10.1038/nature15251 · Cited by 493
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
King, J. C., Xu, J., Wongvipat, J., Hieronymus, H., Carver, B. S., Leung, D. H., Taylor, B. S., Sander, C., Cardiff, R. D., Couto, S. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.371 · Cited by 477
Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers
Hnisz, D., Schuijers, J., Lin, C. Y., Weintraub, A. S., Abraham, B. J., Lee, T. I., Bradner, J. E., & Young, R. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.014 · Cited by 476
A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon, I. S., Davis, J. N., Braun, B. S., Sublett, J. E., Roussel, M. F., Denny, C. T., & Shapiro, D. N. (1995) · PubMed · Cited by 471
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469
A putative second cell-derived oncogene of the avian leukaemia retrovirus E26
Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C., & Stehelin, D. (1983) · Nature · doi:10.1038/306395a0 · Cited by 459
Erkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T.-H., Dakshanamurthy, S., Brown, M. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1983 · Cited by 452
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447
Tripartite structure of the avian erythroblastosis virus E26 transforming gene
Nunn, M. F., Seeburg, P. H., Moscovici, C., & Duesberg, P. H. (1983) · Nature · doi:10.1038/306391a0 · Cited by 423
Brenner, J. C., Ateeq, B., Li, Y., Yocum, A. K., Cao, Q., Asangani, I. A., Patel, S., Wang, X., Liang, H., Yu, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.010 · Cited by 415
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
A new member of the ETS family fused to EWS in Ewing tumors
Peter, M., Couturier, J., Pacquement, H., Michon, J., Thomas, G., Magdelenat, H., & Delattre, O. (1997) · Oncogene · doi:10.1038/sj.onc.1200933 · Cited by 397
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Tomlins, S. A., Aubin, S. M. J., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S., Williamsen, S., Hodge, P., Meinke, J., Blase, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001970 · Cited by 350
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
Chi, P., Chen, Y., Zhang, L., Guo, X., Wongvipat, J., Shamu, T., Fletcher, J. A., Dewell, S., Maki, R. G., Zheng, D., et al. (2010) · Nature · doi:10.1038/nature09409 · Cited by 336
SCF ubiquitin ligase-targeted therapies
Skaar, J. R., Pagan, J. K., & Pagano, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4432 · Cited by 335
Klämbt, C. (1993) · Development · doi:10.1242/dev.117.1.163 · Cited by 332
Xin, J. H., Cowie, A., Lachance, P., & Hassell, J. A. (1992) · Genes & Development · doi:10.1101/gad.6.3.481 · Cited by 330
Understanding TERT Promoter Mutations: A Common Path to Immortality
Bell, R. J. A., Rube, H. T., Xavier-Magalhães, A., Costa, B. M., Mancini, A., Song, J. S., & Costello, J. F. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0003 · Cited by 307
Mehra, R., Tomlins, S. A., Shen, R., Nadeem, O., Wang, L., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin, M. A., Chinnaiyan, A. M., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800769 · Cited by 303
A causal role for ERG in neoplastic transformation of prostate epithelium
Klezovitch, O., Risk, M., Coleman, I., Lucas, J. M., Null, M., True, L. D., Nelson, P. S., & Vasioukhin, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711711105 · Cited by 302
Montero, J. C., Seoane, S., Ocaña, A., & Pandiella, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2616 · Cited by 298
PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
Brenner, J. C., Feng, F. Y., Han, S., Patel, S., Goyal, S. V., Bou-Maroun, L. M., Liu, M., Lonigro, R., Prensner, J. R., Tomlins, S. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3648 · Cited by 290
Chakrabarti, R., Hwang, J., Andres Blanco, M., Wei, Y., Lukačišin, M., Romano, R.-A., Smalley, K., Liu, S., Yang, Q., Ibrahim, T., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2607 · Cited by 285
Chen, Y., Chi, P., Rockowitz, S., Iaquinta, P. J., Shamu, T., Shukla, S., Gao, D., Sirota, I., Carver, B. S., Wongvipat, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3216 · Cited by 282
Yoshimoto, M., Joshua, A. M., Cunha, I. W., Coudry, R. A., Fonseca, F. P., Ludkovski, O., Zielenska, M., Soares, F. A., & Squire, J. A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.96 · Cited by 279
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer
Helgeson, B. E., Tomlins, S. A., Shah, N., Laxman, B., Cao, Q., Prensner, J. R., Cao, X., Singla, N., Montie, J. E., Varambally, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5352 · Cited by 276
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Cai, C., Wang, H., He, H. H., Chen, S., He, L., Ma, F., Mucci, L., Wang, Q., Fiore, C., Sowalsky, A. G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66666 · Cited by 273
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
Bronisz, A., Godlewski, J., Wallace, J. A., Merchant, A. S., Nowicki, M. O., Mathsyaraja, H., Srinivasan, R., Trimboli, A. J., Martin, C. K., Li, F., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2396 · Cited by 270
Self-citationCharacterization of TMPRSS2 -ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
Mehra, R., Tomlins, S. A., Yu, J., Cao, X., Wang, L., Menon, A., Rubin, M. A., Pienta, K. J., Shah, R. B., & Chinnaiyan, A. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6154 · Cited by 269
Birdsey, G. M., Shah, A. V., Dufton, N., Reynolds, L. E., Osuna Almagro, L., Yang, Y., Aspalter, I. M., Khan, S. T., Mason, J. C., Dejana, E., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.11.016 · Cited by 267
Afar, D., Vivanco, I., Hubert, R., Kuo, J., Chen, E., Saffran, D. C., Raitano, A. B., & Jakobovits, A. (2001) · PubMed · Cited by 266
FUS/ERG gene fusions in Ewing's tumors.
Shing, D. C., McMullan, D. J., Roberts, P., Smith, K. K., Chin, S., Nicholson, J. C., Tillman, R. M., Ramani, P., Cullinane, C., & Coleman, N. (2003) · PubMed · Cited by 265
The Ets transcription factor Elf5 specifies mammary alveolar cell fate
Oakes, S. R., Naylor, M. J., Asselin-Labat, M.-L., Blazek, K. D., Gardiner-Garden, M., Hilton, H. N., Kazlauskas, M., Pritchard, M. A., Chodosh, L. A., Pfeffer, P. L., et al. (2008) · Genes & Development · doi:10.1101/gad.1614608 · Cited by 260
Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression
Kim, C. A., Phillips, M. L., Kim, W., Gingery, M., Tran, H. H., Robinson, M. A., Faham, S., & Bowie, J. U. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4173 · Cited by 254
on behalf of the Transatlantic Prostate Group, Reid, A. H. M., Attard, G., Ambroisine, L., Fisher, G., Kovacs, G., Brewer, D., Clark, J., Flohr, P., Edwards, S., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605554 · Cited by 250
Minner, S., Enodien, M., Sirma, H., Luebke, A. M., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1251 · Cited by 249
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
Kaneko, Y., Yoshida, K., Handa, M., Toyoda, Y., Nishihira, H., Tanaka, Y., Sasaki, Y., Ishida, S., Higashino, F., & Fujinaga, K. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<115::aid-gcc6>3.0.co;2-6 · Cited by 239
Heinrich, M. C., Griffith, D., McKinley, A., Patterson, J., Presnell, A., Ramachandran, A., & Debiec-Rychter, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0625 · Cited by 219
ETV6 mutations in early immature human T cell leukemias
Van Vlierberghe, P., Ambesi-Impiombato, A., Perez-Garcia, A., Haydu, J. E., Rigo, I., Hadler, M., Tosello, V., Della Gatta, G., Paietta, E., Racevskis, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20112239 · Cited by 212
The role of the transcription factor Ets1 in carcinoma
Dittmer, J. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.010 · Cited by 212
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203
Noah, T. K., Kazanjian, A., Whitsett, J., & Shroyer, N. F. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.020 · Cited by 202
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
Labussière, M., Di Stefano, A. L., Gleize, V, Boisselier, B., Giry, M., Mangesius, S., Bruno, A., Paterra, R., Marie, Y., Rahimian, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.538 · Cited by 202
Grohar, P. J., Woldemichael, G. M., Griffin, L. B., Mendoza, A., Chen, Q.-R., Yeung, C., Currier, D. G., Davis, S., Khanna, C., Khan, J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr156 · Cited by 202
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Li, Y., Zhou, Q.-L., Sun, W., Chandrasekharan, P., Cheng, H. S., Ying, Z., Lakshmanan, M., Raju, A., Tenen, D. G., Cheng, S.-Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3240 · Cited by 200
Mutant p53 cooperates with ETS2 to promote etoposide resistance
Do, P. M., Varanasi, L., Fan, S., Li, C., Kubacka, I., Newman, V., Chauhan, K., Daniels, S. R., Boccetta, M., Garrett, M. R., et al. (2012) · Genes & Development · doi:10.1101/gad.181685.111 · Cited by 196
ETV6 fusion genes in hematological malignancies: A review
De Braekeleer, E., Douet-Guilbert, N., Morel, F., Le Bris, M.-J., Basinko, A., & De Braekeleer, M. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.04.010 · Cited by 194
Danila, D. C., Anand, A., Sung, C. C., Heller, G., Leversha, M. A., Cao, L., Lilja, H., Molina, A., Sawyers, C. L., Fleisher, M., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.011 · Cited by 192
Transcriptome sequencing identifies ETV6–NTRK3 as a gene fusion involved in GIST
Brenca, M., Rossi, S., Polano, M., Gasparotto, D., Zanatta, L., Racanelli, D., Valori, L., Lamon, S., Dei Tos, A. P., & Maestro, R. (2016) · The Journal of Pathology · doi:10.1002/path.4677 · Cited by 189
Ets1 and ets2 are required for endothelial cell survival during embryonic angiogenesis
Wei, G., Srinivasan, R., Cantemir-Stone, C. Z., Sharma, S. M., Santhanam, R., Weinstein, M., Muthusamy, N., Man, A. K., Oshima, R. G., Leone, G., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211391 · Cited by 185
Self-citationMartin, M. E., Piette, J., Yaniv, M., Tang, W. J., & Folk, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5839 · Cited by 179
Choy, E., Butrynski, J. E., Harmon, D. C., Morgan, J. A., George, S., Wagner, A. J., D’Adamo, D., Cote, G. M., Flamand, Y., Benes, C. H., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-813 · Cited by 176
Zhang, Y., Gong, M., Yuan, H., Park, H. G., Frierson, H. F., & Li, H. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0042 · Cited by 176
Urano, F., Umezawa, A., Hong, W., Kikuchi, H., & Hata, J.-I. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0281 · Cited by 175
Baena, E., Shao, Z., Linn, D. E., Glass, K., Hamblen, M. J., Fujiwara, Y., Kim, J., Nguyen, M., Zhang, X., Godinho, F. J., et al. (2013) · Genes & Development · doi:10.1101/gad.211011.112 · Cited by 175
COP1 is a tumour suppressor that causes degradation of ETS transcription factors
Vitari, A. C., Leong, K. G., Newton, K., Yee, C., O’Rourke, K., Liu, J., Phu, L., Vij, R., Ferrando, R., Couto, S. S., et al. (2011) · Nature · doi:10.1038/nature10005 · Cited by 170
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 168
Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.
Donaldson, L. W., Petersen, J. M., Graves, B. J., & McIntosh, L. P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00340.x · Cited by 161
Landscape of gene fusions in epithelial cancers: seq and ye shall find
Kumar‐Sinha, C., Sundaram, S. K., & Chinnaiyan, A. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0252-1 · Cited by 160
Asangani, I. A., Wilder-Romans, K., Dommeti, V. L., Krishnamurthy, P. M., Apel, I. J., Escara-Wilke, J., Plymate, S. R., Navone, N. M., Wang, S., Feng, F. Y., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0472 · Cited by 158
Han, B., Mehra, R., Dhanasekaran, S. M., Yu, J., Menon, A., Lonigro, R. J., Wang, X., Gong, Y., Wang, L., Shankar, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2014 · Cited by 155
Shimizu, K., Ichikawa, H., Tojo, A., Kaneko, Y., Maseki, N., Hayashi, Y., Ohira, M., Asano, S., & Ohki, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10280 · Cited by 149
Elf5 Regulates Mammary Gland Stem/Progenitor Cell Fate by Influencing Notch Signaling
Chakrabarti, R., Wei, Y., Romano, R.-A., DeCoste, C. J., Kang, Y., & Sinha, S. (2012) · Stem Cells · doi:10.1002/stem.1112 · Cited by 144
SLUG: Critical regulator of epithelial cell identity in breast development and cancer
Phillips, S. M., & Kuperwasser, C. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.972740 · Cited by 137
Span, P. N., Manders, P., Heuvel, J. J. T. M., Thomas, C. M. G., Bosch, R. R., Beex, L. V. A. M., & Sweep, F. C. G. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206040 · Cited by 137
Behrens, P., Rothe, M., Wellmann, A., Krischler, J., & Wernert, N. (2001) · The Journal of Pathology · doi:10.1002/path.844 · Cited by 131
Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
Grohar, P. J., Griffin, L. B., Yeung, C. L., Chen, Q.-R., Pommier, Y. G., Khanna, C., Khan, J. I., & Helman, L. J. (2011) · Neoplasia · doi:10.1593/neo.101202 · Cited by 130
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
Wang, S., Kollipara, R. K., Srivastava, N., Li, R., Ravindranathan, P., Hernández, E., Freeman, E., Humphries, C. G., Kapur, P., Lotan, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322198111 · Cited by 130
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8389 · Cited by 127
Ran, L., Sirota, I., Cao, Z., Murphy, D. A., Chen, Y., Shukla, S., Xie, Y., Kaufmann, M. C., Gao, D., Zhu, S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0985 · Cited by 127
An Ets2 -Driven Transcriptional Program in Tumor-Associated Macrophages Promotes Tumor Metastasis
Zabuawala, T., Taffany, D. A., Sharma, S. M., Merchant, A. S., Adair, B., Srinivasan, R., Rosol, T. J., Fernández, S., Huang, K., Leone, G. W., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1474 · Cited by 127
Self-citationUnderstanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Myers, E., Hill, A. D. K., Kelly, G., McDermott, E. W. M., O’Higgins, N. J., Buggy, Y., & Young, L. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1192 · Cited by 123
Chatterjee, P., Choudhary, G. S., Sharma, A., Singh, K., Heston, W. D. W., Ciezki, J. P., Klein, E. A., & Almasan, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060408 · Cited by 122
Feldman, R. J., Sementchenko, V. I., Gayed, M., Fraig, M., & Watson, D. K. (2003) · PubMed · Cited by 122
An Oncogenic Role for ETV1 in Melanoma
Jané-Valbuena, J., Widlund, H. R., Perner, S., Johnson, L. A., Dibner, A. C., Lin, W. M., Baker, A. C., Nazarian, R. M., Vijayendran, K. G., Sellers, W. R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3092 · Cited by 115
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
Rahim, S., Beauchamp, E. M., Kong, Y., Brown, M. L., Toretsky, J. A., & Üren, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019343 · Cited by 113
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
on behalf of the Transatlantic Prostate Group, Attard, G., Clark, J., Ambroisine, L., Mills, I. G., Fisher, G., Flohr, P., Reid, A. H. M., Edwards, S. E., Kovács, G., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604472 · Cited by 109
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53
Xiong, S., Tu, H., Kollareddy, M., Pant, V., Li, Q., Zhang, Y., Jackson, J. G., Suh, Y., Elizondo-Fraire, A. C., Yang, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404139111 · Cited by 106
Leinonen, K. A., Tolonen, T. T., Bracken, H., Stenman, U., Tammela, T. L. J., Saramäki, O. R., & Visakorpi, T. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2505 · Cited by 104
Yuan, L., Bras, A. L., Sacharidou, A., Itagaki, K., Zhan, Y., Kondo, M., Carman, C. V., Davis, G. E., Aird, W. C., & Oettgen, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300236 · Cited by 103
Longoni, N., Sarti, M., Albino, D., Civenni, G., Malek, A. V., Ortelli, E., Pinton, S., Grand, M. M., Ostano, P., D’Ambrosio, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4537 · Cited by 98
[Chromosomal translocation (11; 22) in cell lines of Ewing's sarcoma].
Turc‐Carel, C., Philip, I., Berger, M., Philip, T. O., & Lenoir, G. (1983) · PubMed · Cited by 95
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Ordóñez, J. L., Amaral, A. T., Carcaboso, A. M., Herrero‐Martín, D., García-Macías, M. D. C., Sevillano, V., Alonso, D., Pascual‐Pasto, G., San‐Segundo, L., Vilà-Ubach, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4303 · Cited by 95
Golay, J., Introna, M., & Graf, T. (1988) · Cell · doi:10.1016/0092-8674(88)90259-0 · Cited by 93
Birdsey, G. M., Dryden, N. H., Shah, A. V., Hannah, R., Hall, M. D., Haskard, D. O., Parsons, M., Mason, J. C., Zvelebil, M., Göttgens, B., et al. (2011) · Blood · doi:10.1182/blood-2011-04-350025 · Cited by 93
Tian, T. V., Tomavo, N., Huot, L., Flourens, A., Bonnelye, E., Flajollet, S., Hot, D., Leroy, X., de Launoit, Y., & Duterque‐Coquillaud, M. (2013) · Oncogene · doi:10.1038/onc.2013.176 · Cited by 92
Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer
Wang, J.-L., Zf, C., Chen, H.-M., Wang, M.-Y., Kong, X., Wang, Y., Sun, T.-T., Hong, J., Zou, W., Xu, J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.206 · Cited by 91
Baker, K. M., Guo, W., Schaffner, A. E., & Ostrowski, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209480200 · Cited by 90
Self-citationGrohar, P. J., Segars, L. E., Yeung, C. L., Pommier, Y. G., D’Incalci, M., Mendoza, A., & Helman, L. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0901 · Cited by 90
Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor
Soldatenkov, V. A., Albor, A., Patel, B. K. R., Dreszer, R., Dritschilo, A., & Notario, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202778 · Cited by 90
Novel Role for PDEF in Epithelial Cell Migration and Invasion
Gunawardane, R. N., Sgroi, D. C., Wrobel, C. N., Koh, E. Y., Daley, G. Q., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1196 · Cited by 89
Shin, S., Kim, T., Jin, F., van Deursen, J. M., Dehm, S. M., Tindall, D. J., Grande, J. P., Munz, J.-M., Vasmatzis, G., & Janknecht, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0941 · Cited by 87
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
Lü, G., Zhang, Q. H., Huang, Y., Song, J., Tomaino, R., Ehrenberger, T., Lim, E., Liu, W., Bronson, R. T., Bowden, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.026 · Cited by 87
Meller, S., Meyer, H., Bethan, B., Dietrich, D., Maldonado, S. G., Lein, M., Montani, M., Reszka, R. C., Schatz, P., Peter, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6370 · Cited by 86
Kalyuga, M., Gallego‐Ortega, D., Lee, H. J., Roden, D. L., Cowley, M. J., Caldon, C. E., Stone, A. M., Allerdice, S. L., Valdés‐Mora, F., Launchbury, R., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001461 · Cited by 84
Regulation of angiogenesis by ETS transcription factors
RANDI, A. M., Sperone, A., Dryden, N. H., & Birdsey, G. M. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371248 · Cited by 84
Targeting mutant p53 in cancer: a long road to precision therapy
Mantovani, F., Walerych, D., & Sal, G. D. (2016) · FEBS Journal · doi:10.1111/febs.13948 · Cited by 81
Gallego‐Ortega, D., Ledger, A., Roden, D. L., Law, A. M. K., Magenau, A., Kikhtyak, Z., Cho, C., Allerdice, S. L., Lee, H. J., Valdés‐Mora, F., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002330 · Cited by 80
Gavrilov, D. K., Kenzior, O., Evans, M., Calaluce, R., & Folk, W. R. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00077-6 · Cited by 78
ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells
Powell, K., Semaan, L., Conley‐LaComb, M. K., Asangani, I. A., Wu, Y.-M., Ginsburg, K., Williams, J. L., Squire, J. A., Maddipati, K. R., Cher, M. L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2352 · Cited by 77
Yang, H., Schramek, D., Adam, R. C., Keyes, B. E., Wang, P., Zheng, D., & Fuchs, E. V. (2015) · eLife · doi:10.7554/elife.10870 · Cited by 77
Charlot, C., Dubois‐Pot‐Schneider, H., Serchov, T., Tourrette, Y., & Wasylyk, B. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_1 · Cited by 75
Hayashi, Y., Bardsley, M. R., Toyomasu, Y., Milosavljevic, S., Gajdos, G. B., Choi, K. M., Reid‐Lombardo, K., Kendrick, M. L., Bingener-Casey, J., Tang, C.-M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.006 · Cited by 74
The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
Seki, Y., Suico, M. A., Uto, A., Hisatsune, A., Shuto, T., Isohama, Y., & Kai, H. (2002) · PubMed · Cited by 72
Cangemi, R., Mensah, A. A., Albertini, V., Jain, A., Grand, M. M., Chiorino, G., Catapano, C. V., & Carbone, G. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210953 · Cited by 72
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
Hensel, T., Giorgi, C., Schmidt, O., Calzada‐Wack, J., Neff, F., Buch, T., Niggli, F. K., Schäfer, B. W., Burdach, S. E. G., & Richter, G. H. S. (2015) · Oncotarget · doi:10.18632/oncotarget.6385 · Cited by 72
Turner, D. P., Moussa, O., Sauane, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2913 · Cited by 71
Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila
Baker, D. A., Mille-Baker, B., Wainwright, S. M., Ish-Horowicz, D., & Dibb, N. J. (2001) · Nature · doi:10.1038/35077122 · Cited by 70
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
Mathsyaraja, H., Thies, K., Taffany, D. A., Deighan, C., Liu, T., Yu, L., Fernández, S., Shapiro, C. L., Otero, J. J., Timmers, C. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.294 · Cited by 70
Self-citationBuchwalter, G., Hickey, M. M., Cromer, A., Selfors, L. M., Gunawardane, R. N., Frishman, J., Jeselsohn, R. M., Lim, E., Chi, D., Fu, X., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.026 · Cited by 70
A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein
Pop, M. S., Stransky, N., Garvie, C. W., Theurillat, J.-P. P., Hartman, E. C., Lewis, T. A., Zhong, C. F., Culyba, E. K., Lin, F., Daniels, D. S., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0689 · Cited by 70
Rahim, S., Minas, T. Z., Hong, S.-H., Justvig, S., Çelik, H., Saygıdeğer, Y., Han, J. J., Kallarakal, A. T., Kong, Y., Rudek, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114260 · Cited by 68
Molecular Pathways: Targeting ETS Gene Fusions in Cancer
Feng, F. Y.-C., Brenner, J. C., Hussain, M., & Chinnaiyan, A. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0275 · Cited by 67
Overexpression of Ets‐1 proto‐oncogene in latent and clinical prostatic carcinomas
ALIPOV, G. K., Nakayama, T., Ito, M., Kawai, K., Naito, S., Nakashima, M., Niino, D., & Sekine, I. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02059.x · Cited by 66
Liang, H., Olejniczak, E. T., Mao, X., Nettesheim, D. G., Yu, L. P., Thompson, C. B., & Fesik, S. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11655 · Cited by 65
HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma
Takeda, S., Liu, H., Sasagawa, S., Dong, Y., Trainor, P. A., Cheng, E. H. Y., & Hsieh, J. J.-D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65566 · Cited by 65
Care, M. A., Cocco, M., Laye, J. P., Barnes, N., Huang, Y., Wang, M., Barrans, S., Du, M., Jack, A., Westhead, D. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku451 · Cited by 65
Mounir, Z., Lin, F., Lin, V., Korn, J. M., Yu, Y., Valdez, R., Aina, O. H., Buchwalter, G., Jaffe, A. B., Korpal, M., et al. (2014) · Oncogene · doi:10.1038/onc.2014.308 · Cited by 64
Patki, M., Chari, V., Sivakumaran, S., Gonit, M., Trumbly, R., & Ratnam, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438473 · Cited by 63
Clinical potential of the ERG oncoprotein in prostate cancer
Rosen, P., Sesterhenn, I. A., Brassell, S. A., McLeod, D. G., Srivastava, S. K., & Dobi, A. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.10 · Cited by 63
Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors
Man, A. K., Young, L. J. T., Tynan, J. A., Lesperance, J., Egeblad, M., Werb, Z., Hauser, C. A., Muller, W. J., Cardiff, R. D., & Oshima, R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8614-8625.2003 · Cited by 62
Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors
Shao, L., Tekedereli, İ., Wang, J., Yuca, E., Tsang, S. V., Sood, A. K., Lopez‐Berestein, G., Özpolat, B., & Ittmann, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2715 · Cited by 62
Scheiber, M. N., Watson, P. M., Rumboldt, T., Stanley, C., Wilson, R. C., Findlay, V. J., Anderson, P. E., & Watson, D. K. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.007 · Cited by 60
Ritter, H. D., Antonova, L., & Mueller, C. R. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0423-t · Cited by 59
Attard, G., Bono, J. S. D., Logothetis, C. J., Fizazi, K. S., Mukherjee, S. D., Joshua, A. M., Schrijvers, D. L. A. L., van den Eertwegh, A. J. M., Li, W., Molina, A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1961 · Cited by 58
Karnes, R. J., Cheville, J. C., Ida, C. M., Sebo, T. J., Nair, A., Tang, H., Munz, J.-M., Kosari, F., & Vasmatzis, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1358 · Cited by 58
Montes‐Moreno, S., Ramos‐Medina, R., Martínez-López, A., Cornejo, C. B., Cubillos, A., Truyenque, S. M. Q., Rodríguez-Pinilla, S. M., Pajares, R., Sánchez-Verde, L., Martinez-Torrecuadrada, J. L., et al. (2012) · Blood · doi:10.1182/blood-2012-08-447599 · Cited by 56
Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer
Verschoor, M. L., & Singh, G. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-138 · Cited by 56
The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26
Nunn, M. F., & Hunter, T. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.398-402.1989 · Cited by 55
Sharma, N. L., Massie, C. E., Butter, F., Mann, M., Bon, H., Ramos‐Montoya, A., Menon, S., Stark, R., Lamb, A. D. G., Scott, H. E., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku281 · Cited by 55
GA-binding protein α/β is a critical regulator of the BRCA1 promoter
Atlas, E., Stramwasser, M., Whiskin, K., & Mueller, C. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203516 · Cited by 55
Targeted Radiosensitization of ETS Fusion-Positive Prostate Cancer through PARP1 Inhibition
Han, S., Brenner, J. C., Sabolch, A. N., Jackson, W., Speers, C. W., Wilder-Romans, K., Knudsen, K. E., Lawrence, T. S., Chinnaiyan, A. M., & Feng, F. Y.-C. (2013) · Neoplasia · doi:10.1593/neo.131604 · Cited by 54
Mesquita, B., Lopes, P., Rodrigues, A., Pereira, D., Afonso, M. G., Leal, C., Henrique, R., Lind, G. E., Jerónimo, C., Lothe, R. A., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2408-2 · Cited by 53
ETS transcription factors and prostate cancer: The role of the family prototype ETS-1 (Review)
Wernert, N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1380 · Cited by 49
The ETS factor TEL2 is a hematopoietic oncoprotein
Carella, C., Potter, M. D., Bonten, J., Rehg, J. E., Neale, G. A. M., & Grosveld, G. C. (2005) · Blood · doi:10.1182/blood-2005-03-1196 · Cited by 45
Lamhamedi-Cherradi, S.-E., Menegaz, B. A., Ramamoorthy, V., Aiyer, R. A., Maywald, R. L., Buford, A. S., Doolittle, D. K., Culotta, K. S., O'Dorisio, J. E., & Ludwig, J. A. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0334 · Cited by 45
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
Cardone, M., Kandilci, A., Carella, C., Nilsson, J. A., Brennan, J. A., Ekmekçi, S. S., Özbek, U., Boyd, K. L., Cleveland, J. L., & Grosveld, G. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2395-2405.2005 · Cited by 45
Casey, O. M., Fang, L., Hynes, P. G., Abou-Kheir, W. G., Martin, P. L., Tillman, H. S., Petrovics, G., Awwad, H. O., Ward, Y., Lake, R. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041668 · Cited by 44
Tumor promoting properties of the ETS protein MEF in ovarian cancer
Yao, J., Liu, Y., Lacorazza, H. D., Soslow, R. A., Scandura, J. M., Nimer, S. D., & Hedvat, C. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210170 · Cited by 43
Chatterjee, P., Choudhary, G. S., Alswillah, T., Xiong, X., Heston, W. D. W., Magi‐Galluzzi, C., Zhang, J., Klein, E. A., & Almasan, A. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0865 · Cited by 43
Boormans, J. L., Hermans, K. G., der Made, A. C. J. Z.-V., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.08.013 · Cited by 41
Ets2 in Tumor Fibroblasts Promotes Angiogenesis in Breast Cancer
Wallace, J. A., Li, F., Balakrishnan, S., Cantemir-Stone, C. Z., Pécot, T., Martin, C. K., Kladney, R. D., Sharma, S. M., Trimboli, A. J., Fernández, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071533 · Cited by 40
Self-citationTEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma
Sang, Y., Chen, M., Luo, D., Zhang, R.-H., Wang, L., Li, M., Luo, R., Qian, C.-N., Shao, J., Zeng, Y.-X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5074 · Cited by 39
Yao, B., Zhao, J., Li, Y., Li, H., Hu, Z., Pan, P., Zhang, Y., Du, E., Liu, R., & Xu, Y. (2015) · The Prostate · doi:10.1002/pros.22970 · Cited by 38
Pitarresi, J. R., Liu, X., Sharma, S. M., Cuitiño, M. C., Kladney, R. D., Mace, T. A., Donohue, S., Nayak, S. G., Qu, C., Lee, J., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.006 · Cited by 37
Self-citationEts2 transcription factor in normal and neoplastic human breast tissue
Buggy, Y., Maguire, T. M., McDermott, E. W. M., Hill, A. D. K., O’Higgins, N. J., & Duffy, M. J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.018 · Cited by 36
Verschoor, M. L., Verschoor, C. P., & Singh, G. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-17 · Cited by 35
Brenne, K., Nymoen, D. A., Falkenthal, T. E. H., Tropé, C. G., & Davidson, B. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.05.023 · Cited by 32
Legrand, A. J., Choul‐li, S., Spriet, C., Idziorek, T., Vicogne, D., Drobecq, H., Dantzer, F., Villeret, V., & Aumercier, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055883 · Cited by 31
The Role of Ets Factors in Tumor Angiogenesis
Oettgen, P. (2010) · Journal of Oncology · doi:10.1155/2010/767384 · Cited by 29
Li, D., Bi, F., Cao, J.-M., Cao, C., Li, C., Liu, B., & Yang, Q. F. (2013) · Oncotarget · doi:10.18632/oncotarget.1549 · Cited by 27
Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer
Ando, M., Kawazu, M., Ueno, T., Koinuma, D., Ando, K., Koya, J., Kataoka, K., Yasuda, T., Yamaguchi, H., Fukumura, K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3816 · Cited by 26
Heo, S., Lee, J.-Y., Yang, K., & Park, K.-S. (2015) · Gene Expression · doi:10.3727/105221615x14399878166276 · Cited by 26
Wu, B., Cao, X., Liang, X., Zhang, X., Zhang, W., Sun, G., & Wang, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117510 · Cited by 24
Thompson, C., MacDonald, G., & Mueller, C. R. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-62 · Cited by 21
Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation
Carrero, Z. I., Kollareddy, M., Chauhan, K. M., Ramakrishnan, G., & Martinez, L. A. (2016) · Oncotarget · doi:10.18632/oncotarget.7275 · Cited by 16
Cited by
The Human Transcription Factors
Lambert, S. A., Jolma, A., Campitelli, L. F., Das, P. K., Yin, Y., Albu, M., Chen, X., Taipale, J., Hughes, T. R., & Weirauch, M. T. (2018) · Cell · doi:10.1016/j.cell.2018.01.029 · Cited by 3,399
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Yuan, X., Larsson, C., & Xu, D. (2019) · Oncogene · doi:10.1038/s41388-019-0872-9 · Cited by 450
Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
Simeonov, K. P., Byrns, C. N., Clark, M. L., Norgard, R. J., Martin, B., Stanger, B. Z., Shendure, J., McKenna, A., & Lengner, C. J. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.005 · Cited by 385
Targeting Transcription Factors for Cancer Treatment
Lambert, M., Jambon, S., Depauw, S., & David-Cordonnier, M.-H. (2018) · Molecules · doi:10.3390/molecules23061479 · Cited by 352
Metadata
- Authors
- Sizemore, G. M., Pitarresi, J. R., Balakrishnan, S., & Ostrowski, M. C.
- Venue
- Nature Reviews Cancer
- Published
- 2017-04-28
- Volume
- 17
- Issue
- 6
- Pages
- 337-351
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2608458533
- Cited by
- 367
- References
- 191
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.